|
|
|
NAFLD
https://pubmed.ncbi.nlm.nih.gov/38278482/ NAFLD
Acad Pediatr. 2024 Jan 24:S1876-2859(24)00018-4.
doi: 10.1016/j.acap.2024.01.019.Online ahead of print.
Missed Opportunities in Guideline-based Fatty Liver Screening among 3.5 million children
Reema Gulati 1, Kabir Gulati 2, Naim Alkhouri 3, Herman Sahni 4, Maroun J Mhanna 5, David C Kaelber 1, Hafiza Mehreen Durrani 1, Roamaa Suri 6
Affiliations expand
PMID: 38278482
DOI: 10.1016/j.acap.2024.01.019
Abstract
Objective: Determine screening rates and examine socio- demographic characteristics of MAFLD screening in a large population of obese children.
https://pubmed.ncbi.nlm.nih.gov/37648793/ NAFLD
Eur J Pediatr. 2023 Aug 30.
doi: 10.1007/s00431-023-05175-x. Online ahead of print.
New predictive models and indices for screening MAFLD in school-aged overweight/obese children
Yunfei Xing 1, PingPing Zhang 2, Xueying Li 1, Shifeng Jin 1, Miao Xu 3, Jinzhu Jia 4, Hai-Jun Wang 1, Li Li # 5, Hui Wang # 6
Abstract
https://pubmed.ncbi.nlm.nih.gov/37384046/ NAFLD
Front Med (Lausanne). 2023 Jun 13;10:1106441.
doi: 10.3389/fmed.2023.1106441.eCollection 2023.
Non-alcoholic fatty liver disease in a pediatric patient with heterozygous familial hypobetalipoproteinemia due to a novel APOB variant: a case report and systematic literature review
Neza Molk 1, Mojca Bitenc 1, Darja Urlep 2 3, Mojca Zerjav Tansek 1 2, Sara Bertok 1 2, Katarina Trebusak Podkrajsek 3 4, Ursa Sustar 1 4, Jernej Kovac 2 4, Tadej Battelino 1 2, Marusa Debeljak 2 4, Urh Groselj 1 2
Abstract
https://pubmed.ncbi.nlm.nih.gov/37384046/ NAFLD
Front Med (Lausanne). 2023 Jun 13;10:1106441.
doi: 10.3389/fmed.2023.1106441.eCollection 2023.
Non-alcoholic fatty liver disease in a pediatric patient with heterozygous familial hypobetalipoproteinemia due to a novel APOB variant: a case report and systematic literature review
Neza Molk 1, Mojca Bitenc 1, Darja Urlep 2 3, Mojca Zerjav Tansek 1 2, Sara Bertok 1 2, Katarina Trebusak Podkrajsek 3 4, Ursa Sustar 1 4, Jernej Kovac 2 4, Tadej Battelino 1 2, Marusa Debeljak 2 4, Urh Groselj 1 2
Abstract
https://pubmed.ncbi.nlm.nih.gov/38268853/ NAFLD
Review
Front Cardiovasc Med. 2024 Jan 10:10:1291438.
doi: 10.3389/fcvm.2023.1291438.eCollection 2023.
Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies
Yan-Lin Liao 1, Gen-Yuan Zhu 1, Cheng Chang 2
Abstract
Background and aims: It is uncertain if there is a link between non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD) in young adults and children. To evaluate the potential link between these two conditions, we conducted a systematic review and meta-analysis of cohort studies.
https://pubmed.ncbi.nlm.nih.gov/34908012/ NAFLD
J Pediatr Gastroenterol Nutr. 2021 Dec 14.
doi: 10.1097/MPG.0000000000003371.Online ahead of print.
Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children with Non-Alcoholic Fatty Liver Disease
Toshifumi Yodoshi 1, Sarah Orkin, Andrew T Trout, Ana Catalina Arce-Clachar, Kristin Bramlage, Chunyan Liu, Lin Fei, Jonathan R Dillman, Stavra A Xanthakos, Marialena Mouzaki
Abstract
Objectives: To develop pediatric-specific models that predict liver stiffness and hepatic steatosis in non-alcoholic fatty liver disease (NAFLD), based on clinical and laboratory data.
https://pubmed.ncbi.nlm.nih.gov/37305367/ NAFLD
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
Dulshan Jayasekera 1, Phillipp Hartmann 2
Abstract
https://pubmed.ncbi.nlm.nih.gov/38418429/ NAFLD
J Gastroenterol Hepatol. 2024 Feb 28.
doi: 10.1111/jgh.16521. Online ahead of print.
PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children
Kyung Jae Lee 1 2, Jin Soo Moon 1, Jin Gyu Lim 1, Homin Huh 1, Jeong Eun Ahn 1, Lia Kim 1, Nan Young Kim 3, Jae Sung Ko 1
Abstract
Background and aim: The aim of this study was to investigate the comprehensive genetic effects of exploratory variants of LYPLAL1, GCKR, HSD17B13, TRIB1, APOC3, MBOAT7, and PARVB on pediatric nonalcoholic fatty liver disease in addition to the previously reported variants of TM6SF2, PNPLA3, and SAMM50 in Korean children.
https://pubmed.ncbi.nlm.nih.gov/38504393/ NAFLD
J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):524-533.
doi: 10.1002/jpn3.12124.Epub 2024 Jan 23.
Pediatricians' practices and knowledge of metabolic dysfunction-associated steatotic liver disease: An international survey
Judith W Lubrecht 1 2 3, Guusje H J van Giesen 1 2, Wojciech Jańczyk 4, Olha Zavhorodnia 5, Natalia Zavhorodnia 5, Piotr Socha 4, Hadar Moran-Lev 6, Anita C E Vreugdenhil 1 2 3; ESPGHAN Fatty Liver Special Interest Group
Affiliations expand
PMID: 38504393
DOI: 10.1002/jpn3.12124
Abstract
https://pubmed.ncbi.nlm.nih.gov/35899133/ NAFLD
Front Pediatr. 2022 Jul 11;10:837116.
doi: 10.3389/fped.2022.837116. eCollection 2022.
Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis
Qun Yu 1 2, Yiwei Liu 1 2, Peipei Hu 1, Feng Gao 1, Guoqing Huang 1
Affiliations expand
PMID: 35899133
PMCID: PMC9311375
DOI: 10.3389/fped.2022.837116
Abstract
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
